{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:25:54Z","timestamp":1779110754748,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020853","name":"SPARTAN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012495","name":"Spondylitis Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["CX001025"],"award-info":[{"award-number":["CX001025"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.semarthrit.2024.152482","type":"journal-article","created":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T05:25:00Z","timestamp":1717305900000},"page":"152482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-2450","authenticated-orcid":false,"given":"Jean W.","family":"Liew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Treu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan A.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk-Lam","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Stovall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Monach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R.","family":"Heckbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne S.","family":"Gensler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine P.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0001","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0002","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1136\/annrheumdis-2018-213317","article-title":"Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis","volume":"78","author":"Mathieu","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152482_bib0003","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","article-title":"Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"Bremander","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0005","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/ken198","article-title":"Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease","volume":"47","author":"Mathieu","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0006","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Sari","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0007","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/annrheumdis-2014-206773","article-title":"CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up","volume":"74","author":"Berg","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"0","key":"10.1016\/j.semarthrit.2024.152482_bib0008","first-page":"1","article-title":"2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"0","author":"Ward","year":"2019","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.semarthrit.2024.152482_bib0009","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase","volume":"296","author":"Mcgettigan","year":"2016","journal-title":"JAMA"},{"issue":"7789","key":"10.1016\/j.semarthrit.2024.152482_bib0010","first-page":"154","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152482_bib0011","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0012","article-title":"Comparative risk of cardiovascular events with biologic and synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a systematicc review and meta-analysis","author":"Singh","year":"2019","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152482_bib0013","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/rheumatology\/kead072","article-title":"Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study","volume":"62","author":"Fakih","year":"2023","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152482_bib0014","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondylitis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152482_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152482_bib0016","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/jamia\/ocv034","article-title":"Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources","volume":"22","author":"Yu","year":"2015","journal-title":"J Am Med Inf Assoc"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0017","first-page":"350","article-title":"Development of phenotype algorithms using electronic medical records and incorporating natural language processing","author":"Liao","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152482_bib0018","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/rheumatology\/kez375","article-title":"Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0019","volume":"Volume 79","year":"2014"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152482_bib0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/art.22682","article-title":"Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152482_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.13063\/2327-9214.1023","article-title":"Validation of diagnostic and procedural codes for identification of acute cardiovascular events in US veterans with rheumatoid arthritis","volume":"1","author":"Davis","year":"2014","journal-title":"eGEMS (Generating Evidence & Methods to improve patient outcomes)"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152482_bib0022","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1525-1497.1999.10198.x","article-title":"Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database","volume":"14","author":"Petersen","year":"1999","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152482_bib0023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pds.1518","article-title":"Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data","volume":"17","author":"Roumie","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152482_bib0024","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.thromres.2015.01.012","article-title":"Improving accuracy of international classification of diseases codes for venous thromboembolism in admistrative data","volume":"135","author":"Sanfilippo","year":"2015","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/art.40084","article-title":"Cardiovascular safety of tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis","volume":"69","author":"Kim","year":"2017","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152482_bib0026","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0027","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the e-value","volume":"167","author":"Vanderweele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152482_bib0028","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2012.02.008","article-title":"No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis - a retrospective cohort study using routine data","volume":"42","author":"Brophy","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152482_bib0029","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-013-2927-5","article-title":"Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population","volume":"34","author":"Chen","year":"2014","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152482_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152482_bib0031","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/rheumatology\/keq316","article-title":"Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"50","author":"Westlake","year":"2011","journal-title":"Rheumatology"},{"issue":"24","key":"10.1016\/j.semarthrit.2024.152482_bib0032","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0033","doi-asserted-by":"crossref","unstructured":"Walsh J.A., Pei S., Penmetsa G., et al. Identification of axial spondyloarthritis patients in a large dataset: the development and validation of novel methods. J Rheumatol. Published online 2019:jrheum.181005. doi:10.3899\/jrheum.181005.","DOI":"10.3899\/jrheum.181005"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152482_bib0034","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"Van Eijk","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152482_bib0035","first-page":"2440","article-title":"Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab","volume":"33","author":"Spanakis","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152482_bib0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2013-203934","article-title":"Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis","volume":"74","author":"Van Sijl","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0037","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year Anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152482_bib0038","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152482_bib0039","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: presenting and interpreting confounder and modifier coefficients","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152482_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41927-021-00207-1","article-title":"Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study","volume":"5","author":"Stovall","year":"2021","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0041","first-page":"13","article-title":"Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs","author":"Chan","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0042","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2018-214388","article-title":"Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study","volume":"78","author":"Avi\u00f1a-Zubieta","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152482_bib0043","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"Bengtsson","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0044","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4103\/0970-2113.192862","article-title":"Ankylosing spondylitis and risk of venous thromboembolism: a systematic review and meta analysis","volume":"33","author":"Ungprasert","year":"2016","journal-title":"Lung India"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152482_bib0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.41580","article-title":"Venous Thromboembolism Risk With JAK Inhibitors: a Meta-Analysis","volume":"73","author":"Yates","year":"2021","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152482_bib0046","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152482_bib0047","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152482_bib0048","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/acr.23088","article-title":"Utilization of care outside the veterans affairs health care system by US veterans with rheumatoid arthritis","volume":"69","author":"Schwab","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2024.152482_bib0049","doi-asserted-by":"crossref","unstructured":"RAND Health. Current and Projected Characteristics and Unique Health Care Needs of the Patient Population Served by the Department of Veterans Affairs.; 2015.","DOI":"10.7249\/RR1165.1"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:13:37Z","timestamp":1726618417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"alternative-id":["S0049017224001227"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152482","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152482"}}